Coronavirus Update: Health experts voice dismay at Texas ban on vaccine mandates
Public health experts reacted with dismay Tuesday to the news of Texas Gov. Greg Abbot's executive order banning any company or entity, public or private, from enforcing COVID-19...
GlaxoSmithKline (GSK) is well-known as a maker of various medications. The company has a huge presence in vaccines, as well as prescription medicines. Its Consumer unit, however,...
Las Vegas, USA, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Acne Vulgaris Pipeline: Therapeutic Assessment, Emerging Drugs, Key Pharma Players, Clinical Trials, and Growth Prospects...
You may have seen that biotech stocks have been in a funk. The IBB has broken through the SMA-200 support line near $160 and it holds a perilous perch at $155, up only about 2.5%...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 8,068.00 | 8,080.00 | 7,972.00 | +140.0 | +1.77% | 175.21K | London | |||
| 41.00 | 41.00 | 41.00 | +6.00 | +17.14% | 3.65M | London | |||
| 903.80 | 908.80 | 898.80 | -2.10 | -0.23% | 3.90M | London | |||
| 3,606.50 | 3,627.50 | 3,593.50 | -1.0 | -0.03% | 2.43M | London | |||
| 49.40 | 49.48 | 49.00 | +0.12 | +0.25% | 113.21M | London | |||
| 8,062.00 | 8,090.00 | 7,944.00 | +140.0 | +1.77% | 423.77K | London | |||
| 169.00 | 173.80 | 165.00 | +5.20 | +3.17% | 219.09K | London | |||
| 958.50 | 972.50 | 944.00 | +11.50 | +1.21% | 302.35K | London | |||
| 296.80 | 297.90 | 293.10 | +2.10 | +0.71% | 2.94M | London | |||
| 223.50 | 223.50 | 223.50 | -2.50 | -1.11% | 1.94K | London | |||
| 544.40 | 550.00 | 539.80 | 0.00 | 0.00% | 0.00 | London | |||
| 274.25 | 274.50 | 269.90 | +4.75 | +1.76% | 15.07M | London | |||
| 3,099.00 | 3,123.00 | 3,068.00 | +31.0 | +1.01% | 148.17K | London | |||
| 2,125.00 | 2,136.00 | 2,096.00 | +34.00 | +1.63% | 315.77K | London | |||
| 143.60 | 152.50 | 143.00 | +0.80 | +0.56% | 2.65M | London |
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.